1
|
Granda P, Villamañán E, Heinz S, Laorden D, Romero D, Añón JM, Carpio C, Sobrino C, Collada V, Domínguez-Ortega J, Herrero A, Quirce S, Álvarez-Sala R. Compassionate Use of Reslizumab in a Life-threatening Asthma Exacerbation. J Investig Allergol Clin Immunol 2024; 34:60-61. [PMID: 37357596 DOI: 10.18176/jiaci.0920] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/27/2023] Open
Affiliation(s)
- P Granda
- Pharmacy Department, Hospital Central de la Defensa Gómez- Ulla, Madrid, Spain
| | - E Villamañán
- Pharmacy Department, Hospital Universitario La Paz, Madrid, Spain
- IdiPAZ, Madrid, Spain
- Medicine Department, Universidad Autónoma de Madrid, Spain
| | - S Heinz
- Pharmacy Department, Hospital Central de la Defensa Gómez- Ulla, Madrid, Spain
| | - D Laorden
- IdiPAZ, Madrid, Spain
- Pulmonology Department, Hospital Universitario La Paz, Madrid, Spain
| | - D Romero
- IdiPAZ, Madrid, Spain
- Intensive Care Unit, Hospital Universitario La Paz, Instituto de Salud Carlos III, Madrid, Spain
| | - J M Añón
- IdiPAZ, Madrid, Spain
- CIBERES, Instituto de Salud Carlos III, Madrid, Spain
- Allergy Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - C Carpio
- IdiPAZ, Madrid, Spain
- Medicine Department, Universidad Autónoma de Madrid, Spain
- Pulmonology Department, Hospital Universitario La Paz, Madrid, Spain
| | - C Sobrino
- Pharmacy Department, Hospital Universitario La Paz, Madrid, Spain
- IdiPAZ, Madrid, Spain
| | - V Collada
- Pharmacy Department, Hospital Universitario La Paz, Madrid, Spain
- IdiPAZ, Madrid, Spain
| | - J Domínguez-Ortega
- IdiPAZ, Madrid, Spain
- Allergy Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - A Herrero
- Pharmacy Department, Hospital Universitario La Paz, Madrid, Spain
- IdiPAZ, Madrid, Spain
| | - S Quirce
- Allergy Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - R Álvarez-Sala
- IdiPAZ, Madrid, Spain
- Medicine Department, Universidad Autónoma de Madrid, Spain
- Pulmonology Department, Hospital Universitario La Paz, Madrid, Spain
| |
Collapse
|
2
|
Lázaro C, Llauradó A, Sánchez-Tejerina D, Cabirta A, Carpio C, Sotoca J, Salvadó M, Raguer N, Restrepo J, Juntas R. [Guillain-Barre syndrome and thrombocytopenia after SARS-CoV-2 vaccination with Moderna. A case report]. Rev Neurol 2022; 75:247-250. [PMID: 36218255 DOI: 10.33588/rn.7508.2022138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
INTRODUCTION The massive vaccination against the SARS-CoV-2 virus has demonstrated to be one of the major measures for the reduction of the morbidity and mortality that this virus causes. However, during the last months the administration of the vaccine has been also associated with some rare, but life-threatening, adverse effects. CASE REPORT In this article we describe the case of a patient that developed a Guillain-Barre syndrome and an Idiopathic thrombocytopenic purpura nine days after the vaccination with the third dose for the SARS-CoV-2 virus (Moderna). He had received previously two doses of the AstraZeneca vaccine. Moreover, the patient was positive for auto-antibodies anti-SSA/Ro60 and auto-antibodies IgG anti-GM1 and IgG anti-GM3. DISCUSSION Even though it is not possible to stablish a clear relation of causality between the administration of the vaccine booster for SARS-CoV-2 and the diseases developed by the patient, the association of two concomitant autoimmune processes is remarkable. As well as the positivity for the auto-antibodies anti-SSA/Ro60, which have been described in the bibliography in cases of SARS-CoV-2 infection.
Collapse
Affiliation(s)
- C Lázaro
- Hospital Universitari Vall d'Hebron, 08035 Barcelona, España
| | - A Llauradó
- Hospital Universitari Vall d'Hebron, 08035 Barcelona, España
| | | | - A Cabirta
- Hospital Universitari Vall d'Hebron, 08035 Barcelona, España
| | - C Carpio
- Hospital Universitari Vall d'Hebron, 08035 Barcelona, España
| | - J Sotoca
- Hospital Universitari Vall d'Hebron, 08035 Barcelona, España
| | - M Salvadó
- Hospital Universitari Vall d'Hebron, 08035 Barcelona, España
| | - N Raguer
- Hospital Universitari Vall d'Hebron, 08035 Barcelona, España
| | - J Restrepo
- Hospital Universitari Vall d'Hebron, 08035 Barcelona, España
| | - R Juntas
- Hospital Universitari Vall d'Hebron, 08035 Barcelona, España
| |
Collapse
|
3
|
Carpio C, Lerín M, Torres I, Fernández-Velilla M, García Río F, Álvarez-Sala R, Prados C. Factors predicting 6-min walking test indexes in adults with cystic fibrosis. Sci Sports 2022. [DOI: 10.1016/j.scispo.2021.06.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
4
|
Villamañán E, Fernández de Uzquiano E, García E, Sobrino C, del Pozo A, Carpio C, Herrero A, Armada E, Álvarez-Sala R, Castro A. Liderazgo de la mujer en la investigación clínica: estudio observacional retrospectivo durante dos décadas en España. Rev Clin Esp 2022. [DOI: 10.1016/j.rce.2022.07.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
5
|
Michot J, Carpio C, Nastoupil L, Chavez J, Feldman T, Ferrari S, Morillo D, Bachy E, Pinto A, Kuruvilla J, Buchholz TJ, Kasibhatla S, Carrancio S, Guarinos C, Wu F, Li S, Patah P, Pourdehnad M. A PHASE 1, MULTICENTER, OPEN‐LABEL STUDY OF CC‐99282 ALONE AND IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMAS. Hematol Oncol 2021. [DOI: 10.1002/hon.89_2881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- J.‐M. Michot
- Gustave Roussy Institute of Cancer Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP) Villejuif France
| | - C. Carpio
- Vall d'Hebron Institute of Oncology (VHIO) University Hospital Vall d'Hebron University Autònoma of Barcelona (UAB) Department of Hematology Barcelona Spain
| | - L. Nastoupil
- MD Anderson Cancer Center University of Texas Department of Lymphoma & Myeloma Houston Texas USA
| | - J. Chavez
- Moffitt Cancer Center University of South Florida Department of Malignant Hematology Tampa Florida USA
| | - T. Feldman
- Hackensack Meridian Health Lymphoma Division Edison New Jersey USA
| | - S. Ferrari
- Papa Giovanni XXIII Hospital Dipartimento di Ematologia Bergamo Italy
| | - D. Morillo
- Hospital Fundación Jiménez Díaz Department of Hematology Madrid Spain
| | - E. Bachy
- Hospices Civils de Lyon Department of Hematology Lyon France
| | - A. Pinto
- National Cancer Institute Fondazione G. Pascale IRCCS Hematology‐Oncology & Stem Cell Transplantation Unit Napoli Italy
| | - J. Kuruvilla
- Princess Margaret Cancer Centre Cancer Clinical Research Unit Division of Medical Oncology and Hematology Toronto Canada
| | - T. J. Buchholz
- Bristol Myers Squibb Early Clinical Development Oncology Princeton New Jersey USA
| | - S. Kasibhatla
- Bristol Myers Squibb Translational Biology Oncogenesis Therapeutic Research Center Princeton New Jersey USA
| | - S. Carrancio
- Bristol Myers Squibb Translational Biology Oncogenesis Therapeutic Research Center Princeton New Jersey USA
| | - C. Guarinos
- Bristol Myers Squibb ONC‐TRC CITRE Princeton New Jersey USA
| | - F. Wu
- Bristol Myers Squibb Clinical Pharmacology Early Clinical Development Princeton New Jersey USA
| | - S. Li
- Bristol Myers Squibb Global Biometric Sciences Princeton New Jersey USA
| | - P. Patah
- Bristol Myers Squibb Early Clinical Development Hematology/Oncology and Cell Therapy Princeton New Jersey USA
| | - M. Pourdehnad
- Bristol Myers Squibb Early Clinical Development Hematology/Oncology and Cell Therapy Princeton New Jersey USA
| |
Collapse
|
6
|
Moreno V, Vieito Villar M, Sepulveda Sanchez J, Galvao V, Hernández Guerrero T, Doger B, Saavedra O, Carlo Stella C, Michot JM, Italiano A, Magagnoli M, Carpio C, Sarmiento R, Amoroso B, Aronchik I, Filvaroff E, Hanna B, Pinto A, Nikolova Z, Braña I. 8MO CC-90010, a reversible, potent oral bromodomain and extraterminal inhibitor (BETi) in patients (pts) with advanced solid tumours (aSTs) and relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Longer follow-up from parts A & B and first reporting of part C of a phase I study. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.01.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
7
|
Vilcacundo R, Barrio D, Carpio C, García-Ruiz A, Rúales J, Hernández-Ledesma B, Carrillo W. Digestibility of Quinoa (Chenopodium quinoa Willd.) Protein Concentrate and Its Potential to Inhibit Lipid Peroxidation in the Zebrafish Larvae Model. Plant Foods Hum Nutr 2017; 72:294-300. [PMID: 28831659 DOI: 10.1007/s11130-017-0626-1] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Quinoa protein concentrate (QPC) was extracted and digested under in vitro gastrointestinal conditions. The protein content of QPC was in the range between 52.40 and 65.01% depending on the assay used. Quinoa proteins were almost completely hydrolyzed by pepsin at pH of 1.2, 2.0, and 3.2. At high pH, only partial hydrolysis was observed. During the duodenal phase, no intact proteins were visible, indicating their susceptibility to the in vitro simulated digestive conditions. Zebrafish larvae model was used to evaluate the in vivo ability of gastrointestinal digests to inhibit lipid peroxidation. Gastric digestion at pH 1.2 showed the highest lipid peroxidation inhibition percentage (75.15%). The lipid peroxidation activity increased after the duodenal phase. The digest obtained at the end of the digestive process showed an inhibition percentage of 82.10%, comparable to that showed when using BHT as positive control (87.13%).
Collapse
Affiliation(s)
- R Vilcacundo
- Laboratorio de Alimentos Funcionales, Facultad de Ciencia e Ingeniería en Alimentos, Universidad Técnica de Ambato, Av. Los Chasquis y Rio Payamino, Ambato, Ecuador
| | - D Barrio
- Universidad Nacional de Rio Negro, Don Bosco y Leloir s/n (8500) Río Negro, Viedma, Argentina
| | - C Carpio
- Laboratorio de Alimentos Funcionales, Facultad de Ciencia e Ingeniería en Alimentos, Universidad Técnica de Ambato, Av. Los Chasquis y Rio Payamino, Ambato, Ecuador
| | - A García-Ruiz
- Department of Food Science and Biotechnology, Escuela Politécnica National, P.O. Box 17-01, 2759, Quito, Ecuador
| | - J Rúales
- Department of Food Science and Biotechnology, Escuela Politécnica National, P.O. Box 17-01, 2759, Quito, Ecuador
| | - B Hernández-Ledesma
- Instituto de Investigación en Ciencias de la Alimentación, (CIAL, CSIC-UAM, CEI UAM+CSIC), Nicolás Cabrera, 9, 28049, Madrid, Spain
| | - W Carrillo
- Laboratorio de Alimentos Funcionales, Facultad de Ciencia e Ingeniería en Alimentos, Universidad Técnica de Ambato, Av. Los Chasquis y Rio Payamino, Ambato, Ecuador.
| |
Collapse
|
8
|
Kaplan J, Gordon L, Infante J, Popat R, Rambaldi A, Madan S, Patel M, Gritti G, El-Sharkawi D, Chau I, Radford J, Perez De Oteyza J, Zinzani P, Iyer S, Faucette S, Sheldon-Waniga E, Stumpo K, Shou Y, Carpio C, Bosch F. TAK-659, AN INVESTIGATIONAL REVERSIBLE DUAL SYK/FLT-3 INHIBITOR, IN PATIENTS WITH LYMPHOMA: UPDATED RESULTS FROM DOSE-ESCALATION AND EXPANSION COHORTS OF a PHASE 1 STUDY. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_60] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- J. Kaplan
- Department of Medicine; Northwestern University; Chicago USA
| | - L. Gordon
- Robert H Lurie Comprehensive Cancer Center; Northwestern University Feinberg School of Medicine; Chicago USA
| | - J. Infante
- Drug Development Unit; Sarah Cannon Research Institute/Tennessee Oncology; Nashville USA
| | - R. Popat
- NIHR Clinical Research Facility; UCLH; London UK
| | - A. Rambaldi
- Dipartimento di Oncologia ed Emato-Oncologia / Hematology and Bone Marrow Transplant Unit; Università degli Studi di Milano / Ospedale Papa Giovanni XXII; Bergamo Italy
| | - S. Madan
- Dipartimento di Oncologia ed Emato-Oncologia/Hematology and Bone Marrow Transplant Unit; Università degli Studi di Milano/Ospedale Papa Giovanni XXIII; Bergamo Italy
| | - M.R. Patel
- Hematology-Oncology; Florida Cancer Specialists/Sarah Cannon Research Institute; Sarasota USA
| | - G. Gritti
- Hematology and Bone Marrow Transplant Unit; Ospedale Papa Giovanni XXIII; Bergamo Italy
| | - D. El-Sharkawi
- Haematology; NIHR UCLH Clinical Research Facility; London UK
| | - I. Chau
- Department of Medicine; Royal Marsden Hospital; Surrey UK
| | - J. Radford
- Manchester Academic Health Science Centre; University of Manchester and the Christie NHS Foundation Trust; Manchester UK
| | | | - P. Zinzani
- Hematology, Institute of Hematology “Seragnoli”; University of Bologna; Bologna Italy
| | - S. Iyer
- Advanced Therapeutics, Institute of Academic Medicine; Houston Methodist Cancer Center; Houston USA
| | - S. Faucette
- Clinical Pharmacology; Takeda Pharmaceuticals International Co.; Cambridge USA
| | | | - K. Stumpo
- Oncology Clinical Research; Takeda Pharmaceuticals; Cambridge USA
| | - Y. Shou
- Oncology Clinical Research; Takeda Pharmaceuticals International Co.; Cambridge USA
| | - C. Carpio
- Hematology; University Hospital Vall d'Hebron; Barcelona Spain
| | - F. Bosch
- Hematology; University Hospital Vall d'Hebron; Barcelona Spain
| |
Collapse
|
9
|
Merchan B, Casares V, Salamero O, Carpio C, Gallur L, Molero A, Blanco A, Montoro J, Tazon B, Valcarcel D. Characteristics and Prognosis of Patients Diagnosed with AML and MDS Who Were Excluded from Clinical Trials. A Retrospective Single-Center Analysis. Leuk Res 2017. [DOI: 10.1016/s0145-2126(17)30195-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
10
|
Zem G, Ter‐Papyan H, Arvizu S, Nernsuan J, Rabizadeh S, Amidi M, Nazari S, Waas S, Lee S, Orujyan A, Manookian L, Taghinia P, Carpio C, Trinh D, Balazadeh H, Oppenheimer SB. Edge assay: kinetic analysis of reagents affecting cell clumping. FASEB J 2013. [DOI: 10.1096/fasebj.27.1_supplement.650.14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Gregory Zem
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - H Ter‐Papyan
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - S Arvizu
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - J Nernsuan
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - S Rabizadeh
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - M Amidi
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - S Nazari
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - S Waas
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - S Lee
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - A Orujyan
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - L Manookian
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - P Taghinia
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - C Carpio
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - D Trinh
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - H Balazadeh
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| | - S B Oppenheimer
- Center for Cancer and Developmental BiologyCalifornia State University NorthridgeNorthridgeCA
| |
Collapse
|
11
|
Dangles O, Carpio C, Barragan AR, Zeddam JL, Silvain JF. Temperature as a key driver of ecological sorting among invasive pest species in the tropical Andes. Ecol Appl 2008; 18:1795-809. [PMID: 18839773 DOI: 10.1890/07-1638.1] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
Invasive species are a major threat to the sustainable provision of ecosystem products and services, both in natural and agricultural ecosystems. To understand the spatial arrangement of species successively introduced into the same ecosystem, we examined the tolerance to temperature and analyzed the field distribution of three potato tuber moths (PTM, Lepidoptera: Gelechiidae), that were introduced in Ecuador since the 1980s. We studied physiological responses to constant temperatures of the three PTM species under laboratory conditions and modeled consequences for their overall population dynamics. We then compared our predictions to field abundances of PTM adults collected in 42 sites throughout central Ecuador. Results showed that the three PTM species differed with respect to their physiological response to temperature. Symmetrischema tangolias was more cold tolerant while Tecia solanivora had the highest growth rates at warmer temperatures. Phthorimaea operculella showed the poorest physiological performance across the range of tested temperatures. Overall, field distributions agree with predictions based on physiological experiments and life table analyses. At elevations >3000 m, the most cold-tolerant species, S. tangolias, was typically dominant and often the only species present. This species may therefore represent a biological sensor of climate change. At low elevations (<2700 m), T. solanivora was generally the most abundant species, probably due to its high fecundity at high temperatures. At mid elevations, the three species co-occurred, but P. operculella was generally the least abundant species. Consistent with these qualitative results, significant regression analyses found that the best predictors of field abundance were temperature and a species x temperature interaction term. Our results suggest that the climatic diversity in agricultural landscapes can directly affect the community composition following sequential invasions. In the tropical Andes, as in other mountain ecosystems, the wide range of thermal environments found along elevational gradients may be one reason why the risks of invasion by successively introduced pest species could increase in the near future. More data on potential biological risks associated with climatic warming trends in mountain systems are therefore urgently needed, especially in developing nations where such studies are lacking.
Collapse
Affiliation(s)
- O Dangles
- Pontificia Universidad Católica del Ecuador, Facultad de Ciencias Exactas y Naturales, Laboratorio de Entomología, Quito, Ecuador.
| | | | | | | | | |
Collapse
|
12
|
Abad-Franch F, Paucar A, Carpio C, Cuba CA, Aguilar HM, Miles MA. Biogeography of Triatominae (Hemiptera: Reduviidae) in Ecuador: implications for the design of control strategies. Mem Inst Oswaldo Cruz 2001; 96:611-20. [PMID: 11500757 DOI: 10.1590/s0074-02762001000500004] [Citation(s) in RCA: 85] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Chagas disease control strategies strongly depend on the triatomine vector species involved in Trypanosoma cruzi transmission within each area. Here we report the results of the identification of specimens belonging to various species of Triatominae captured in Ecuador (15 species from 17 provinces) and deposited in the entomological collections of the Catholic University of Ecuador (Quito), Instituto Oswaldo Cruz (Brazil), the Natural History Museum London (UK), the London School of Hygiene and Tropical Medicine (UK), the National Institute of Hygiene (Quito), and the Vozandes Hospital (Quito). A critical review of published information and new field records are presented. We analysed these data in relation to the life zones where triatomines occur (11 life zones, excluding those over 2,200 m altitude), and provide biogeographical maps for each species. These records are discussed in terms of epidemiological significance and design of control strategies. Findings relevant to the control of the main vector species are emphasised. Different lines of evidence suggest that Triatoma dimidiata is not native to Ecuador-Peru, and that synanthropic populations of Rhodnius ecuadoriensis in southern Ecuador-northern Peru might be isolated from their sylvatic conspecifics. Local eradication of T. dimidiata and these R. ecuadoriensis populations might therefore be attainable. However, the presence of a wide variety of native species indicates the necessity for a strong longitudinal surveillance system.
Collapse
Affiliation(s)
- F Abad-Franch
- Pathogen Molecular Biology and Biochemistry Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
| | | | | | | | | | | |
Collapse
|
13
|
Abad-Franch F, Noireau F, Paucar A, Aguilar HM, Carpio C, Racines J. The use of live-bait traps for the study of sylvatic Rhodnius populations (Hemiptera: Reduviidae) in palm trees. Trans R Soc Trop Med Hyg 2000; 94:629-30. [PMID: 11198645 DOI: 10.1016/s0035-9203(00)90213-x] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Affiliation(s)
- F Abad-Franch
- Pathogen Molecular Biology and Biochemistry Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
| | | | | | | | | | | |
Collapse
|
14
|
Perez-Regadera J, Murillo M, Sancho S, Sanchez-Rodillo G, Guereña M, Prados R, Ludeña B, Cabeza M, Carpio C, Bartolome A, Lanzos E. Acute and late toxicity in the adjuvant radiotherapy of endometrial carcinoma. Analysis of 215 patients. Eur J Cancer 1997. [DOI: 10.1016/s0959-8049(97)85648-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
15
|
Carpio C, Murillo MT, Pe´rez-Regadera J, Cabeza MA, Ramos A, De la Cruz J, Sa´nchez G, Sancho S, Ferna´ndez de Leto´n P, Lanzo´s E. 163 Brachytherapy for penis cancer. Radiother Oncol 1996. [DOI: 10.1016/0167-8140(96)87966-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|